Presentation TCT 2016 To Treat or Not to Treat (Focally): From Stable to PROSPECT-ABSORB and PREVENT Presenter: Gregg W. Stone, Ron Waksman, Seung-Jung Park November 01, 2016
Presentation TCT 2016 Bioresorbable Scaffolds for Vulnerable Plaque Treatment: Rationale for Focal Therapy, Early Clinical Experiences, and Will it Succeed?! Presenter: Gregg W. Stone, Ron Waksman, Vasim Farooq November 01, 2016
Presentation TCT 2016 Detecting and Differentiating Plaque Erosion vs Rupture and Does It Matter? Presenter: John A. Ambrose, Peter H. Stone, Giulio Guagliumi November 01, 2016
Presentation TCT 2016 Strengths and Limitations of OCT to Detect Vulnerable Plaque: A Critical Appraisal Presenter: John A. Ambrose, Peter H. Stone, Guillermo Tearney November 01, 2016
Presentation TCT 2016 NIRS Detection of Vulnerable Plaque: The Story Is Intensifying Presenter: John A. Ambrose, Peter H. Stone, David Erlinge November 01, 2016
Presentation TCT 2016 What Makes a Plaque Vulnerable: Morphology, Chemistry, Biologic Activity, or Ischemia? Presenter: John A. Ambrose, Peter H. Stone November 01, 2016
Presentation TCT 2016 The Greatest Misconceptions Doctors STILL Believe About Vulnerable Plaques and Patients: Reflections From a Pioneer Presenter: John A. Ambrose, Peter H. Stone, James E. Muller November 01, 2016
Presentation TCT 2016 CKD, Atherosclerosis, and Vascular Calcification: Essentials for the Interventionalist Presenter: Somjot S. Brar, Richard Solomon, Anand Prasad November 01, 2016
Presentation TCT 2016 TCT 359: Ulnar Artery Transient Compression Facilitating Radial Artery patent hemostasis (ULTRA). A Novel Technique to Reduce Radial Artery Occlusion Presenter: Ivo Bernat, Thomas M. Tu November 01, 2016
Presentation TCT 2016 TCT 358: Bleeding and Vascular Complication Rates Before and After Implementation of a Radial Coronary Catheterization Programme an Observational Study in 12 745 Patients Presenter: Ivo Bernat, Thomas M. Tu November 01, 2016
Presentation TCT 2016 TCT 547: Radial Artery Changes After Transradial PCI A Serial Optical Coherence Tomography Volumetric Study Presenter: Ivo Bernat, Thomas M. Tu November 01, 2016
News Industry News Sudy Indicates PCI Of NIRS-Defined Lipid-Rich Plaque Is Safe And Not Associated With A Greater Incidence Of Adverse Outcomes Compared To PCI of Non Lipid-Rich Plaque November 01, 2016
Presentation TCT 2016 TCT 96: Progression of Coronary Atherosclerosis Despite Lipid-Lowering Therapy in Diabetic Patients Compared to Non-Diabetic Ones. Study With 3D Intravascular Ultrasound and Virtual Histology Presenter: Farouc Jaffer, Amir Lerman, Tomas Kovarnik October 31, 2016
Presentation TCT 2016 TCT 95: The Interplay Between Features of Plaque Vulnerability and Hemodynamic Relevance of Coronary Artery Stenoses Presenter: Farouc Jaffer, Amir Lerman, Sabahattin Umman October 31, 2016
Presentation TCT 2016 TCT 94: Impact of Thin-Cap Fibroatheromas on Unanticipated Ischemic Events in Medically Treated Patients With Diabetes Mellitus: Insights From the PROSPECT Study Presenter: Farouc Jaffer, Amir Lerman, Elvin Kedhi October 31, 2016
Presentation TCT 2016 TCT 93: Near-Infrared Spectroscopy-Derived Lipid Core Burden Index Predicts Major Adverse Cardiovascular Events in Patients With Coronary Artery Disease During 4.3 Year Follow-up Presenter: Farouc Jaffer, Amir Lerman, Eric Boersma October 31, 2016
Presentation TCT 2016 DISRUPT CAD: A multicenter, prospective, single-arm study of percutaneous lithoplasty prior to stent implantation in heavily calcified coronary lesions Presenter: Joseph A. Hill, Steven P. Marso, Todd J. Brinton October 31, 2016
Presentation TCT 2016 YELLOW II: Relationship of Serial Change in Plaque Morphology of Obstructive Non-Culprit Lesions to HDL Efflux, Inflammation and Transcriptome Perturbations in Response to High-Dose Statin Therapy Presenter: Spencer B. King III, Jagat Narula, Annapoorna Kini October 31, 2016
Presentation TCT 2016 Lower Extremity Vascular Disease Intervention: Live Case Review (Wellmont Holston Valley Hospital) Presenter: Julie Logan October 30, 2016
News Daily News Lowering LDL With Statins and Other Selected Agents Should Be Focus of CVD Risk Reduction, Analysis Implies Michael O'Riordan September 27, 2016